ACP
SNY icon

Arcus Capital Partners’s Sanofi SNY Stock Holding History

Arcus Capital Partners’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-5,195
Closed -$226K – 106
2018
Q4 		$226K Buy
5,195
+273
+6% +$12K 0.13% 83
2018
Q3 		$220K Buy
+4,922
New +$210K 0.1% 96

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Arcus Capital Partners's SNY Position: Q1 2019 in Review

Arcus Capital Partners sold out of Sanofi (SNY) in Q1 2019, closing a stake of 5,195 shares — an estimated $226K sold.

Arcus Capital Partners first reported a position in SNY in Q3 2018 and held it in 2 quarters. The position peaked at $226K in Q4 2018. 488 funds tracked by Wall St. Rank hold SNY as of Q1 2019.

  • Arcus Capital Partners reported no remaining Sanofi position as of Q1 2019 after selling out during the quarter.
  • Arcus Capital Partners sold 5,195 Sanofi shares in Q1 2019, an estimated $226K.
  • Arcus Capital Partners first reported a position in Sanofi in Q3 2018 and held it in 2 quarters.
  • Arcus Capital Partners's Sanofi position peaked at $226K in Q4 2018.
  • 488 funds tracked by Wall St. Rank held Sanofi as of Q1 2019.

Based on Arcus Capital Partners's 13F filing for Q1 2019, filed 29 Apr 2019.